Price$23.67-0.64 (-2.63%)
2026-03-052026-06-08
News · 26 weeks68+133%
2025-12-142026-06-07
Mix3790d
- Insider24(65%)
- SEC Filings6(16%)
- Other4(11%)
- Earnings2(5%)
- Analyst1(3%)
Latest news
25 items- PREnovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and TeensSpinamic combines the curve-correction efficacy of rigid bracing with the comfort and mobility of dynamic braces, offering an optimal balance of therapy and patient wearabilityAvailable in 10 off-the-shelf sizes with an adjustable three-point pressure system, the brace enables fitting, imaging, and adjustment in a single visitSpinamic is now available in the United States, with regulatory clearance being pursued across additional markets worldwide DALLAS, TX, June 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven medical technology company, today announced the launch of the DonJoy Spinamic® Hybrid Scoliosis Brace, to be distributed by its subsidiary, DJO,
- INSIDERChief Administrative Officer Engert Oliver bought $22,220 worth of shares (1,000 units at $22.22), increasing direct ownership by 2% to 49,640 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- SECSEC Form SD filed by Enovis CorporationSD - Enovis CORP (0001420800) (Filer)
- INSIDERDirector Shirley Brady was granted 9,346 shares, increasing direct ownership by 9% to 110,589 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Lalor Angela S was granted 9,346 shares, increasing direct ownership by 42% to 31,486 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Ortiz Christine was granted 9,346 shares, increasing direct ownership by 60% to 25,011 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Bodem Barbara W. was granted 9,346 shares, increasing direct ownership by 63% to 24,201 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Okala Philip was granted 9,346 shares, increasing direct ownership by 63% to 24,201 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Wienbar Sharon L was granted 9,346 shares, increasing direct ownership by 29% to 41,946 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Perfall A Clayton was granted 9,346 shares, increasing direct ownership by 21% to 54,190 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Vinnakota Rajiv was granted 9,346 shares, increasing direct ownership by 33% to 37,608 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Kelly Liam was granted 9,346 shares, increasing direct ownership by 48% to 28,950 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- SECSEC Form S-8 filed by Enovis CorporationS-8 - Enovis CORP (0001420800) (Filer)
- SECEnovis Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Enovis CORP (0001420800) (Filer)
- INSIDERSVP, Chief Financial Officer Berry Phillip Benjamin (Ben) covered exercise/tax liability with 7,774 shares, decreasing direct ownership by 5% to 150,822 units (SEC Form 4) to cover withholding tax4 - Enovis CORP (0001420800) (Issuer)
- INSIDERChief Executive Officer Mcdonald Damien covered exercise/tax liability with 12,634 shares, decreasing direct ownership by 5% to 234,042 units (SEC Form 4) (withholding tax)4 - Enovis CORP (0001420800) (Issuer)
- SECSEC Form 10-Q filed by Enovis Corporation10-Q - Enovis CORP (0001420800) (Filer)
- SECEnovis Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Enovis CORP (0001420800) (Filer)
- PREnovis Announces First Quarter 2026 ResultsFirst-quarter sales growth of 5% on a reported basisFirst-quarter Reconstructive sales grew 11% on a reported basisReiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash Flow Conversion guidance Dallas, TX, May 07, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation ("Enovis" or "the Company") (NYSE:ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended April 3, 2026. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET. First Quarter 2026 Financial Results Enovis' first-quarter net sales of $589 million grew 5% on a reported basis and 3
- SECSEC Form SCHEDULE 13G filed by Enovis CorporationSCHEDULE 13G - Enovis CORP (0001420800) (Subject)
- ANALYSTWilliam Blair resumed coverage on Enovis CorporationWilliam Blair resumed coverage of Enovis Corporation with a rating of Outperform
- INSIDERSEC Form 3 filed by new insider Singleton Laura Lee3 - Enovis CORP (0001420800) (Issuer)
- PREnovis to Host First Quarter 2026 Results Conference Call on May 7thDallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2026 financial results on Thursday, May 7th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com. Conference Call/Webcast Information Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-987
- SECSEC Form DEFA14A filed by Enovis CorporationDEFA14A - Enovis CORP (0001420800) (Filer)
- SECSEC Form DEF 14A filed by Enovis CorporationDEF 14A - Enovis CORP (0001420800) (Filer)
ENOV FAQ
6 questionsWhat does Enovis Corporation do?
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular...Where does ENOV stock trade?
Enovis Corporation (ENOV) is listed on NYSE.What sector and industry is ENOV in?
Enovis Corporation operates in the Health Care sector, Industrial Specialties industry.What are analysts saying about ENOV?
Enovis Corporation has had 8 recent analyst actions on file. The most recent action was from William Blair: Outperform on 2026-04-17. Recent price targets cluster around $4100.00.What companies are similar to ENOV?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare ENOV side-by-side with any of them on Quantisnow.How can I track ENOV on Quantisnow?
Quantisnow aggregates Enovis Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ENOV to receive live email and push alerts on every new disclosure.